Read the latest on emerging therapies, review important clinical trials and explore future treatment and management
.go to activity»
Vinod K. Rustgi, MD, MBA, is a distinguished professor of medicine in the division of gastroenterology and hepatology at Rutgers University’s Robert Wood Johnson Medical…go to activity»
This activity is supported by an educational grant from Aries Pharmaceuticals Inc.
Expiration Date: 2/1/2019
Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to…go to activity»
Anil K. Rustgi, MD, serves as the division chief of gastroenterology at the University of Pennsylvania's Perelman School of Medicine in Philadelphia. Rustgi and his…go to activity»
This educational activity is supported by an independent medical educational grant from Merck & Co., Inc.
Expiration Date: 2/5/2019
The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that…go to activity»
This activity is supported by independent educational grants from AbbVie; Pfizer; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.
Expiration Date: 1/23/2019
Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. There is…go to activity»